Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas

Completed · Phase 2

Conditions studied: Pancreatic Cancer

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more that one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combining gemcitabine and docetaxel in treating patients who have locally advanced or metastatic cancer of the pancreas.

Key facts

Study ID

NCT00003810

Run by

Eastern Cooperative Oncology Group

Starts

1999-08-11

Last updated by the study team

2023-06-15

Who can join

Age: 18 and older, up to 120. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Indiana University Cancer Center — Indianapolis, Indiana, United States
• Greater Baltimore Medical Center and Cancer Center — Baltimore, Maryland, United States
• Johns Hopkins Oncology Center — Baltimore, Maryland, United States
• New England Medical Center Hospital — Boston, Massachusetts, United States
• Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States
• CCOP - Missouri Valley Cancer Consortium — Omaha, Nebraska, United States
• Veterans Affairs Medical Center - Nashville — Nashville, Tennessee, United States
• Vanderbilt Cancer Center — Nashville, Tennessee, United States
• Veterans Affairs Medical Center - Madison — Madison, Wisconsin, United States
• University of Wisconsin Comprehensive Cancer Center — Madison, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.